Variant report
Variant | esv3429730 |
---|---|
Chromosome Location | chr2:168161506-168165004 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:168158037..168159768-chr2:168162619..168165474,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs117865681 | chr2:168161515-168161516 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs115226282 | chr2:168161528-168161529 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs117336865 | chr2:168161565-168161566 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs541158948 | chr2:168161583-168161584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs554790242 | chr2:168161608-168161609 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs75223163 | chr2:168161628-168161629 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs151088685 | chr2:168161688-168161689 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs563961130 | chr2:168161693-168161694 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs577515639 | chr2:168161728-168161729 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs147589213 | chr2:168161751-168161752 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs545805893 | chr2:168161762-168161763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs199861582 | chr2:168161765-168161766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs370468281 | chr2:168161769-168161770 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs182107861 | chr2:168161786-168161787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs374515193 | chr2:168161836-168161837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs187782666 | chr2:168161937-168161938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs373660621 | chr2:168161956-168161957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs548272507 | chr2:168161969-168161970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs113925383 | chr2:168162036-168162037 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs192262499 | chr2:168162039-168162040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs184040385 | chr2:168162097-168162098 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs550547154 | chr2:168162142-168162143 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs570713962 | chr2:168162147-168162148 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs78861268 | chr2:168162151-168162152 | Weak transcription | n/a | n/a | Overlapped CNVs | mRNA abundance |
25 | rs552133094 | chr2:168162172-168162173 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs565711361 | chr2:168162220-168162221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs118112873 | chr2:168162233-168162234 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs78356572 | chr2:168162273-168162274 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs574841128 | chr2:168162284-168162285 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs563663099 | chr2:168162297-168162298 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs532384187 | chr2:168162361-168162362 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs149695166 | chr2:168162371-168162372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs80227580 | chr2:168162391-168162392 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs577597117 | chr2:168162480-168162481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs188578288 | chr2:168162490-168162491 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs560105287 | chr2:168162526-168162527 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs576658100 | chr2:168162540-168162541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs572834167 | chr2:168162544-168162545 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs559587338 | chr2:168162570-168162571 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs113483412 | chr2:168162572-168162573 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs140244771 | chr2:168162578-168162579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs530559382 | chr2:168162606-168162607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs550733139 | chr2:168162618-168162619 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs1357599 | chr2:168162630-168162631 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs547147329 | chr2:168162667-168162668 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs532983935 | chr2:168162734-168162735 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs546457892 | chr2:168162779-168162780 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs79042802 | chr2:168162851-168162852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs534655209 | chr2:168162889-168162890 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs567226274 | chr2:168162945-168162946 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
myoclonus epilepsy | 18472482 | CNVD |
Benign familial neonatal-infantile seizures | 18472482 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Mental retardation | 22214275 | CNVD |
Glioblastoma | 21080181 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Autism | 18414403 | CNVD |
Developmental delay | 21147756 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neonatal seizures | 20384724 | CNVD |
severe myoclonic epilepsy of infancy | 18294202 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Schizophrenia | 21346763 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:168151400-168163600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
2 | chr2:168152000-168174400 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
3 | chr2:168152600-168167000 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
4 | chr2:168154400-168173600 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr2:168154800-168165800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
6 | chr2:168157200-168163000 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
7 | chr2:168160200-168164800 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
8 | chr2:168160400-168165000 | Weak transcription | iPS-15b Cell Line | embryonic stem cell |
9 | chr2:168163000-168163400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr2:168163400-168165600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
11 | chr2:168164800-168167400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr2:168165000-168167600 | Enhancers | iPS-15b Cell Line | embryonic stem cell |